NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N′-(4-chlorophenyl)urea (LY 181984) at an external site  by James Morré, D.
,;;-: ~ .7 ¸ 
ELSEVIER Biochimica et Biophysica Acta 1240 (1995) 201-208 
BB 
Biochi~ic~a et Biophysica ~ta 
NADH oxidase activity of HeLa plasma membranes inhibited by the 
antitumor sulfonylurea 
N-(4-methylphenylsulfonyl) -N'-(4-chlorophenyl) urea ( LY 181984) at an 
external site 
D.  James Morr6 * 
Department of Medicinal Chemistr3', Hansen Life Sciences Research Building, Purdue Unil:ersity, West Lafayette, IN47907, USA 
Received 16 May 1995; accepted 10 August 1995 
Abstract 
NADH oxidase activity from HeLa plasma membranes was inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N'- 
(4-chlorophenyl)urea (LY181984). With sealed right side-out vesicles, the drug inhibited half maximally at about 30 nM and the 
inhibition was nearly complete. A closely related but growth-inactive sutfonylurea, N-(4-methylphenylsulfonyl)-N'-(phenyl)urea 
(LY181985), did not inhibit the activity. With plasma membranes first solubilized with 2% Triton X-100, activity also was inhibited by 
LY181984 and not by LY181985 but the maximum inhibition at 10 txM LY181984 was only 50%. When sealed right side-out plasma 
membrane vesicles were frozen and thawed repeatedly to evert some of the vesicles into an inside-out configuration, the NADH oxidase 
activity again was only about 50% inhibited by 1 /xM LY181984. In such preparations, the right side-out vesicles exhibited an 
electrophoretic mobility greater than that of the inside-out vesicles. Sidedness was confirmed by measurements of ATPase latency and 
binding of immunogold-labeled concanavalin A. When the two vesicle populations were resolved by preparative free-flow electrophore- 
sis, the active antitumor sulfonylurea LY181984 inhibited only the NADH oxidase activity of the right side-out vesicles. These findings 
suggested two NADH sites or activity isoforms for the plasma membrane NADH oxidase. One activity, inhibited by LY181984, appeared 
to be accessible to external NADH only with sealed right side-out vesicles. The other, not inhibited by LYI81984, was accessible to 
NADH only with inside-out vesicles or after membrane disruption by Triton X-100. The findings demonstrate hat the NADH oxidation 
site inhibited as a result of binding the active antitumor sulfonylurea LYI81984 is at the external cell surface. Plasma membrane vesicles 
from HeLa cells are able to oxidize NADH supplied to either membrane surface but only with inside-out vesicles is NADH oxidation 
sensitive to inhibition by the antitumor sulfonylurea. 
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1. Introduction 
We previously reported that HeLa plasma membranes 
bind the active antitumor sulfonylurea LY181984 with 
high affinity (K  d of ca. 30 nM) [1]. Upon sulfonylurea 
binding, the plasma membrane vesicles of HeLa cells 
exhibited a sulfonylurea-inhibited oxidation of NADH [2]. 
The latter was inhibited with an EDs0 of about 30 nM. The 
Abbreviations: Con A, concanavalin A; LYI81984, N-(4-methylphen- 
ylsulfonyl)-N'-(4-chlorophenyl)urea; LY181985, N-(4-methylphenyl- 
sulfonyl)-N'-(phenyl)urea. 
* Corresponding author. Fax: + 1 (317) 4944007. 
0005-2736/95/$09.50 © 1995 Elsevier Science B.V. All rights reserved 
SSDI0005-2736(95)00199-9 
inhibition was analyzed kinetically and found to be uncom- 
petitive [2]. 
In this report, we demonstrate that plasma membranes 
of HeLa cells contain at least two NADH oxidase activi- 
ties. One is inhibited by the antitumor sulfonylurea, the 
other is not. For these studies, sulfonylureas active and 
inactive in the inhibition of growth of in vivo murine solid 
tumors [3,4] were provided by Lilly Research Laboratories 
(Indianapolis). The compounds have a high degree of 
efficacy and a relatively low toxicity [4,6]. Of these, one 
active and one inactive in inhibiting growth of HeLa cells 
in parallel to that of the murine tumors [5], were selected 
for detailed study. 
To explore the orientation within the plasma membrane 
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of the two forms of NADH oxidase activity, sealed right 
side-out HeLa plasma membrane vesicles were treated to 
yield a mixture of right side-out and inside-out vesicles [7]. 
The two populations were separated by preparative free- 
flow electrophoresis and sidedness was verified using 
well-established marker criteria. Only when NADH, an 
impermeant substrate, was supplied to right side-out vesi- 
cles was NADH oxidation inhibited by the sulfonylurea. 
Taken together with detergent solubilization experiments, 
the results provide evidence for two forms of NADH 
oxidase associated with the plasma membranes of HeLa 
cells, one external and inhibited by the active antitumor 
sulfonylurea nd one internal and resistant to inhibition by 
the active antitumor sulfonylurea. 
2. Materials and methods 
diluted with 5 volumes of cold 1 mM NaHCO s and the 
membranes were collected by centrifugation. The purity of 
the plasma membrane was determined to be > 90% by 
electron microscope morphometry. The yield was 2 mg 
plasma membrane protein from 109 cells. 
2.3. Spectrophotometric assay 
NADH oxidase activity was determined as the disap- 
pearance of NADH measured at 340 nm in a reaction 
mixture containing 25 mM Tris-Mes buffer, pH 7.2, 1 mM 
KCN to inhibit any potential mitochondrial oxidase activ- 
ity, and 150 /zM NADH at 37°C with constant stirring. 
Activity was measured using a Hitachi U3210 with contin- 
uous recording over 5 or 10 min intervals. A millimolar 
extinction coefficient of 6.22 was used to determine NADH 
disappearance. 
2.1. Growth of cells 2.4. Right side-out vs. inside-out membrane vesicles 
HeLa S cells were grown on minimal essential medium 
(S-MEM) (Jolik modified) with glutamine (244 mg/1) and 
phosphate (1.3 g / l  Na2HPO 4) and without CaC12 plus 5% 
donor horse serum. Gentamycin sulfate (50 mg/1) and 
sodium bicarbonate (2 g/ l )  were added. Cells were col- 
lected by centrifugation for 6 to 15 min at 1000 to 3000 
rpm (e.g., 6 min at 3000 rpm or 15 min at 1000 rpm). 
2.2. Purification of plasma membranes from HeLa cells 
HeLa cells grown as suspension cultures were collected 
by centrifugation for 6 min at 3000 rpm. The cell pellets 
were resuspended in 0.2 mM EDTA in 1 mM NaHCO 3 in 
an approximate ratio of 1 ml per 108 cells and incubated 
on ice for 30 min to swell the cells. Homogenization was 
with a Polytron homogenizer for 40 s at 10500 rpm using 
an ST-probe and 8 ml aliquots. Cell breakage was at least 
90% without breakage of nuclei as determined by light 
microscopy. 
The homogenates were centrifuged for 10 min at 175 × 
g to remove unbroken cells and nuclei. The supernatant 
was centrifuged a second time at 1.4. 106X g min to 
prepare a plasma membrane-enriched fraction. Plasma 
membrane-enriched pellets were resuspended in 0.2 M 
potassium phosphate buffer in a ratio of 1 ml per pellet 
from approx. 5. 108 cells. The resuspended membranes 
were then loaded onto the two-phase system constituted on 
a weight basis and consisting of 6.5% (w/w)  Dextran 
T-500 (Pharmacia), 6.4% (w/w) poly(ethylene glycol) 
3350 (Fisher) in 5 mM potassium phosphate buffer, pH 7.2 
[8]. The resuspended microsomal pellet (1 g) was added to 
the two-phase system and the weight of the system was 
brought to 8 g with distilled water. The tubes were in- 
verted vigorously for 40 times in the cold (4°C) and the 
phases separated by centrifugation at 150 x g for 5 min. 
The upper phases were withdrawn with a pasteur pipette, 
For preparation of right side-out and inside-out mem- 
brane vesicles, sealed right side-out HeLa plasma mem- 
brane vesicles were subjected to a series of freeze-thaw 
treatments followed by hypotonic lysis facilitated by draw- 
ing the suspended vesicles through a fine hypodermic 
needle. This procedure verted some of the vesicles into a 
cytoplasmic side-out configuration [7]. The cytoplasmic 
side-out vesicles lacked the strongly negatively charged 
surface molecules that characterize right side-out vesicles 
and the two populations were readily resolved by prepara- 
tive free-flow electrophoresis [7]. 
Free-flow electrophoresis separations were as described 
[9]. The mixture of right side-out and inside-out vesicles 
was suspended in chamber buffer (see below). The equip- 
ment was a VAP-22 continuous free-flow electrophoresis 
unit (Bender and Hobein, Munich, Germany). The elec- 
trophoresis medium (chamber buffer) consisted of 0.25 M 
sucrose, 2.0 mM KCI, 10 mM triethanolamine, and 10 mM 
acetic acid, pH 6.5 (NaOH). The electrode buffer con- 
tained 100 mM triethanolamine and 100 mM acetic acid, 
pH 6.5 (NaOH). The separations were carried out at 4°C 
under a constant voltage of 1150 V over the 9.2 cm field 
with a resulting current of 180 _ 5 mA. The buffer flow 
was 1.7 ml/fraction/h and the sample injection was 2.7 
ml/h. The separation profile was monitored by collecting 
individual fractions and monitoring absorbance at 280 nm. 
The membranes were collected from pooled fractions by 
centrifugation for 30 min at 95 000 X g (Beckman SW-28). 
2.5. ATPase latency assays to verify vesicle orientation 
An assay of total ATPase activity was conducted in a 
500 ~! reaction volume containing 25 mM Tris-Mes, pH 
6.5, 1 mM NaN 3, 1 mM sodium molybdate, 0.1 mM 
EDTA, 3.0 mM MgSO4, 3.0 mM disodium ATP, 50 mM 
KC1, and 5 to 10 /zg plasma membrane protein. Reactions 
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were incubated at room temperature for 30 rain and stopped 
by addition of 50 #zl 25% TCA and 300/~1 1% SDS. The 
released phosphate was determined by addition of 2.5 ml 
freshly prepared reagent containing 0.8% ammonium 
molybdate, 0.27% ascorbic acid, and 0.045% SnCI 2 in 1 N 
H2SO 4. The absorbance at 723 nm was measured after 30 
min. 
Protein was measured by the bicinchoninic acid proce- 
dure [10] with bovine serum albumin as the standard. 
2.6. Concanat~,alin A (Con A) binding 
The membrane pellets were washed twice with 1.5 ml 
of 5 mM Hepes-KOH, pH 7.2, containing 0.25 M sorbitol 
(to approximate the concentration of sucrose in the free- 
flow electrophoresis buffer) by centrifugation in a mi- 
crofuge (Eppendorf) for 5 min. The pellets were resus- 
pended in the same buffer to give a 100 /zg protein/100 
ktl solution. An equal volume of a solution of 10 /,tg Con 
A conjugated with 20 nm immunogold (Sigma)/100 /xl 
(10% of total protein) was added to the membrane suspen- 
sions. After incubation for 40 min at room temperature, 1.5 
ml of 2.5% glutaraldehyde in 0. ! M sodium phosphate, pH 
7.2, followed by centrifugation for 5 min in the microfuge. 
The supernatant was discarded, fresh 2.5% glutaraldehyde 
in phosphate buffer, pH 7.2, was added, and the material 
was processed for electron microscopy. 
2.7. Electron microscopy 
Small wedges cut from membrane pellets fixed with 
2.5% glutaraldehyde in 0.05 M sodium phosphate, pH 7.2, 
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Fig. 2. Absorbance profiles at 280 nm of free-flow electrophoretic 
separations of HeLa cell plasma membranes. Membranes prepared by 
aqueous two-phase partition were frozen and thawed and passed through 
a narrow gauge needle to invert some of the vesicles. The right side-out 
vesicles (A) were then separated from the cytoplasmic side-out vesicles 
(B) by preparative free-flow electrophoresis. 
were rinsed three times with 0.05 M sodium phosphate, pH 
7.2, and post-fixed with 1% osmium tetroxide in 0.05 M 
sodium phosphate, pH 7.2, overnight at 4°C. Samples were 
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Fig. I. NADH oxidase activity of HeLa plasma membranes with increasing concentrations of LY181984. (A) Solid symbols and lines (lower curve). 
Sealed right side-out vesicles of HeLa plasma membranes. The antitumor sulfonylurea LY181984 active in inhibition of tumor growth resulted in nearly 
complete inhibition of NADH oxidase activity. Open symbols, dashed lines (upper curve). With vesicles of plasma membranes that were repeatedly frozen 
and then thawed, the NADH oxidase was only about 50% inhibited by LY181984. (B) HeLa plasma membranes solubilized with 0.1% Triton X-100. 
Inhibition of NADH oxidase by the antitumor active LY181984 (solid symbols) was about 50%. For each experiment duplicate determinations were 
averaged. Results are averages from three experiments + S.D. among experiments. 
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dehydrated in an acetone series, and embedded in Epon 
[11]. Lead-stained thin sections were examined and photo- 
graphed with a Philips EM/200. 
3. Results 
The NADH oxidase activity of vesicles of plasma mem- 
branes of HeLa cells is inhibited by the antitumor sulfony- 
lurea active in growth inhibition, N-(4-methylphenyl- 
sulfonyl)-N'-(4-chlorophenyl)urea (LY181984) (Fig. 1). 
The degree of maximum inhibition, however, varied from 
nearly complete (Fig. 1A) to about 50% (Fig. 1A,B) 
depending on whether or not vesicles were pretreated to 
expose both external and internal membrane surfaces. 
With sealed right side-out vesicles, the NADH oxidase 
was nearly completely inhibited by LY181984 (Fig. 1A, 
lower curve). Half maximal inhibition was at about 30 nM 
LY181984 and maximum inhibition was achieved at about 
1 ttM. 
When plasma membrane preparations that had been 
repeatedly frozen and thawed were analyzed, some of the 
vesicles became verted with the result being a mixture of 
vesicles of smaller diameter some of which were right 
side-out and some of which were inside-out. When such 
preparations were assayed for NADH oxidase activity, the 
activity was still inhibited by LY181984 with near maxi- 
mum inhibition at about 1 #M. However, on average, the 
maximum inhibition was only about 50% (Fig. I A, upper 
curve) as compared to > 90% for the sealed, right side-out 
vesicles of Fig. I A (lower curve). 
LY181984 inhibited as well in detergent-solubilized 
preparations of plasma membranes from HeLa cells (Fig. 
1B). As with frozen and thawed vesicles, the inhibition by 
LY181984 was only about 50%. That the inhibition of the 
activity by LY 181984 in detergent-solubilized preparations 
was only 50% compared to intact membranes suggested 
that there might be at least two NADH sites or activity 
isoforms associated with the plasma membrane, one inhib- 
ited by sulfonylurea nd the other not inhibited. 
With each of the different plasma membrane prepara- 
tions of Fig. IA and Fig. 1B, a chemically related but 
growth inactive sulfonylurea, N-(4-methylphenylsulfonyl)- 
N'-(phenyl)urea (LY181985), was tested at the same con- 
centrations as for LY181984. Within the standard evia- 
tions among the two preparations analyzed (+ 10%), the 
LY 181985 was without effect (data not shown). 
NADH, being impermeant, can reach an outside site 
Fig. 3. Electron micrographs of HeLa plasma membrane fractions purified by aqueous two-phase partition and separated by preparative fr e-flow 
electrophoresis into two fractions of differing electrophoretic mobility. (A) Electrophoretic fraction of greatest mobility and high ATPase latency consisting 
of right side-out vesicles. (B) Electrophoretic fraction of lesser mobility and low ATPase latency consisting ofinside-out vesicles. Both classes of vesicles 
appeared tobe sealed. Scale bar = 0.5 ,~m. 
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only with right side-out vesicles and would be accessible 
to an inside site only with inside-out vesicles. To test the 
suggestion that the sulfonylureas inhibit only the oxidase 
activity exposed to NADH with right side-out vesicles, i.e., 
an external NADH site, HeLa cell plasma membranes were 
subfractionated into separate populations of inside-out and 
right side-out vesicles. To effect this separation, a HeLa 
cell plasma membrane preparation obtained by aqueous 
two-phase partition was frozen and thawed several times 
and a portion of the vesicles were everted by passing them 
through a narrow gauge needle. The right side-out vesicles 
carried a net negative surface charge greater than that of 
the inside-out vesicles and thus were resolved by prepara- 
tive free-flow electrophoresis a illustrated in Fig. 2. The 
plasma membrane fractions of greatest electrophoretic mo- 
bility, fractions 38-42 (A), were combined as representing 
fight side-out vesicles and fractions 43 to 47 (B) of lesser 
electrophoretic mobility were combined as representing 
inside-out vesicles. 
Electron microscopy of the isolated vesicles revealed 
relatively uniform populations of closed vesicles following 
free-flow electrophoretic separations (Fig. 3). More than 
90% of the vesicles had morphological characteristics of
plasma membranes. The membrane vesicles were large, 
smooth (lacking ribosomes or electron transport particles) 
and were 9 to 10 nm in thickness. Additionally, the plasma 
membranes when contrasted with lead showed clearly the 
dark-light-dark pattern characteristic of the plasma mem- 
brane. There was little or no perceptible contamination by 
endoplasmic reticulum (6 nm thick membranes, attached 
Fig. 4. Binding of 20 nm immunogold-labeled concanavalin A to purified plasma membranes of HeLa cells. Membrane vesicles were isolated by aqueous 
two-phase partition and freeze-thaw disruption was used to evert some of the vesicles from a right side-out o an inside-out configuration. Subsequent 
separation was by preparative free-flow electrophoresis fractions enriched in right side-out and inside-out vesicles. By reacting with surface glycoproteins, 
the external plasma membrane surface was marked. (A) Vesicles of electrophoresis fractions 38-42 bound concanavalin A and were right side-out 
(cytoplasmic side-in). (B) Vesicles of electrophoresis fractions 43-47 bound concanavalin A poorly and were inside-out (cytoplasmic side-out). Of the 
vesicles in the right side-out fraction > 90% were marked by concanavalin A. Of the vesicles in the inside-out fraction < 10% were marked by 
concanavalin A. Scale bar = 0.5 /zm. 
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ribosomes), mitochondria (cristae and fj/fo-ATPase), 
Golgi apparatus (stacked cisternae) or nuclear envelope 
(presence of chromatin and 6 nm membranes with pores). 
The appearance of the right side-out membranes (Fig. 3A) 
and of the inside-out membranes (Fig. 3B) was similar 
except hat cytoplasmic debris (e.g., free ribosomes) was 
located dominantly on the outside of the right side-out 
vesicles (Fig. 3A) but frequently appeared to be contained 
within the inside-out vesicles (Fig. 3B) as might be ex- 
pected from accidental entrapment during the eversion 
process. 
To determine sidedness, the latency of ATP activity 
was determined. Both the starting vesicles and the more 
electrophoretically mobile right side-out vesicles exhibited 
only low ATPase activity unless detergent was added to 
disrupt the vesicles (Table 1). In contrast, the inside-out 
vesicles exhibited the same high ATPase activity both 
before and after detergent-disruption of the membranes. 
Orientation of the vesicles in the two different elec- 
trophoretic fractions was determined from concanavalin A 
binding visualized by electron microscopy using concana- 
valin A conjugated with 20 nm immunogold (Fig. 4). The 
initial plasma membrane isolates from two-phase partition 
were mixtures of vesicles reacting strongly and of vesicles 
reacting weakly with immunogold-linked to concanavalin 
A. However, with vesicles first separated into two popula- 
tions by preparative free-flow electrophoresis, the 
strongly-reactive sicles were concentrated in fraction A 
of the more electronegative part of the separation (Fig. 4A) 
whereas the weakly reactive vesicles were concentrated in 
fraction B in the least electronegative part of the separation 
(Fig. 4B). Latency of concanavalin A inhibition of 5'- 
nucleotidase was exhibited by vesicles of fraction B but 
not by vesicles of fraction A. These findings suggest hat 
the two populations of plasma membrane vesicles obtained 
by preparative free-flow electrophoresis (Fig. 4) resulted 
from the presence of both inside-out and right side-out 
plasma membrane vesicles and their subsequent resolution 
by free-flow electrophoresis. 
When right side-out and cytoplasmic side-out plasma 
membrane vesicles from HeLa plasma membranes were 
compared, the inhibition of NADH oxidase activity by the 
active antitumor sulfonylurea LY181984 was seen only 
with the right side-out vesicles (Fig. 5, solid symbols). The 
dose response was equivalent to that observed with the 
starting preparations of sealed right side-out vesicles (Fig. 
I A, lower curve). Inhibition was > 90% complete and 
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Fig. 5. NADH oxidase activity of free-flow electrophoretic separations of
inside-out (solid symbols) and right side-out plasma membrane vesicles 
(open symbols) in response to the logarithm of the concentrations of the 
active antitumor sulfonylurea LY181984. The NADH oxidase activity of 
the more electrophoretically mobile fractions corresponding to fraction A 
(electrophoresis fractions 38-42) of Fig. 5 was inhibited by the sulfo- 
nylurea whereas the activity of less electrophoretically mobile fractions 
corresponding to fraction B (electrophoresis fractions 43 to 47) of Fig. 5 
was unaffected by the antitumor sulfonylurea. Values are averages of 
duplicate determinations for each of three different experiments+S.D. 
among experiments. 
near maximal at 1 /zM. The concentration for half-maxi- 
mal inhibition was about 30 nM. In contrast, the fraction 
enriched in inside-out vesicles did not respond to 
LY181984 (Fig. 5, open symbols). 
Comparing the same fractions as analyzed for Fig. 5, 
the right side-out vesicles that responded to the active 
antitumor suifonylurea, LY 181984, again did not respond 
to the growth inactive sulfonylurea analog LY 181985 (data 
not shown). An overall inhibition of about 20% at 10 -4 M 
LY181985 was observed with the inside-out vesicle frac- 
tions. 
Intact HeLa cells oxidized NADH in the absence of 
added external oxidants at rates comparable to those exhib- 
ited by isolated plasma membranes. This oxidation of 
NADH via an external plasma membrane site also was 
inhibited by the growth-active antitumor sulfonylurea 
LY181984 but not by LY181985 (data not shown). These 
findings provide additional support for the existence of an 
external NADH site at the cell surface responsive to the 
antitumor sulfonylureas. 
4. Discussion 
Table 1 
ATPase latency of HeLa plasma membrane (/xmol P I /h /mg protein) 
0.2% Triton X-100 
Fraction - + 
Fraction A right side-out < 0.5 6.4 
Fraction B inside-out 5.5 7.1 
The sulfonylurea antitumor agents are unknown in their 
mode of action. Plasma membranes i olated from HeLa 
cells bind [3H]LYI81984 with high affinity (K d of 20-50 
nM) [1]. A binding protein was subsequently identified 
[12] and the isolated plasma membrane vesicles were 
shown to exhibit a sulfonylurea-inhibited NADH oxidase 
activity [2]. 
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In this report, we provide additional evidence that the 
NADH oxidase of HeLa plasma membranes i  sensitive to 
inhibition by active (LY181984) but not inactive 
(LY181985) experimental sulfonylurea ntitumor agents. 
With the sulfonylurea active in inhibition of HeLa growth, 
this inhibition occurs at very low doses of drug. Half 
maximal inhibition is observed at about 30 nM. 
A major anomaly of the inhibition data with LY 181984 
was that the drug inhibited the NADH oxidase of intact, 
right side-out vesicles nearly completely. However, with 
detergent-disrupted membranes, NADH oxidase activity 
was inhibited only by about 50%. With both preparations, 
maximal inhibition was obtained at an optimum LY 181984 
concentration of about ! /zM. When assays were con- 
ducted on populations of membrane vesicles that had been 
frozen and thawed to yield a mixture of inside-out and 
right side-out vesicles [13], the inhibition also was only 
about 50%, suggestive of a differential response of a 
surface exposed NADH site compared to an internal site. 
With HeLa cells, the plasma membrane isolates from 
aqueous two-phase partition were electrophoretically ho- 
mogeneous. However, after repeated freezing and thawing 
accompanied by passing the membrane through a narrow 
gauge needle [14] to evert some of the vesicles, the 
preparations exhibited an electrophoretic heterogeneity that 
appeared to result from the presence of two distinct popu- 
lations of vesicles of different orientations. The existence 
of two plasma membrane populations were observed previ- 
ously in free-flow electrophoretic separations of total cell 
homogenates based on measurements of the plasma mem- 
brane marker K÷-stimulated, ouabain-inhibited, p- 
nitrophenylphosphatase [15]. One population was clearly 
resolved as a highly electrophoretically mobile fraction of 
plasma membrane vesicles. The second population was of 
lower electrophoretic mobility. That plasma membrane 
vesicles of different orientations could be resolved by 
preparative free-flow electrophoresis was first indicated 
from work with erythrocyte ghosts [14]. 
The two populations of HeLa plasma membrane vesi- 
cles resolved by preparative free-flow electrophoresis from 
the purified plasma membranes prepared by aqueous two- 
phase partition were subsequently characterized as to con- 
tent and orientation of plasma membrane markers. The 
population of greatest electrophoretic mobility was shown 
from concanavalin A binding and latency measurements to 
exhibit a right side-out orientation whereas the fraction of 
lesser electrophoretic mobility consisted of vesicles ex- 
hibiting an inside-out orientation [7]. 
When HeLa plasma membrane vesicles were resolved 
after freezing and thawing into enriched populations of 
right side-out and inside-out vesicles, the NADH oxidase 
inhibited by LY181984 was associated largely with the 
right side-out vesicles. Therefore, there appeared to be two 
NADH binding sites capable of supporting NADH oxidase 
activity. One appeared to be on the outside of the plasma 
membrane and inhibited by sulfonylurea. The other is on 
the inside and not inhibited by sulfonylurea. At present it 
is not known if these differences represent two sites on a 
common transmembrane complex, different isoforms of 
differing sulfonylurea responsiveness or completely differ- 
ent activities, one sulfonylurea responsive and the other 
sulfonylurea unresponsive. 
An external NADH site for NADH oxidation by mam- 
malian cells is supported by observations that intact cells 
oxidize NADH in the absence of external electron accep- 
tors [16,17]. NADH is normally regarded as being imper- 
meant. That this external site corresponds to the external 
site deduced from the vesicle sidedness studies is indicated 
since with HeLa and HeLa S cells grown in culture, the 
NADH oxidation by intact cells is sulfonylurea-responsive 
(L.-Y. Wu, D.M. Morr6 and D.J. MorrO, unpublished 
results). 
Why the plasma membrane should have an external 
NADH site cannot be answered at present. Since intact 
cells oxidize NADH directly and this NADH oxidation is 
sulfonylurea-inhibited, theexternal site appears to be both 
present and functional. However, cells either in culture or 
in tissues, would rarely have access to reduced pyridine 
nucleotide. A likely explanation is that the extemal site, 
while capable of oxidizing NADH, normally is involved in 
some function (e.g., protein disulfide-thiol interchange [18]) 
other than the direct oxidation of NADH. 
The function of the plasma membrane NADH oxidase 
and especially the growth factor and/or hormone-stimu- 
lated component [19,20] is unknown. However, the NADH 
oxidase of plasma membranes from transformed cells and 
tissues fails to respond to growth factors and hormones 
[21,22]. Thus the oxidase, or some proteins associated with 
the response of the NADH oxidase to hormones and 
growth factors appears to be altered in transformation. 
Similarly, the oxidase activity of HeLa cell plasma mem- 
branes and plasma membranes of human colon adeno- 
carcinoma [23] or ras-transformed rat kidney cells re- 
sponds to the antitumor sulfonylureas [24] whereas that of 
rat liver and normal rat kidney cells does not. One would 
expect hat an antitumor drug directed to a site altered in 
transformation might be both selective and effective. The 
NADH oxidase activity of the HeLa plasma membrane 
would represent such a site. Its apparent accessibility to 
NADH only with right side-out vesicles and its inhibition 
by an active anticancer sulfonylurea suggests that the 
oxidase or some associated protein may function as an 
extracellular target of antitumor drug action. 
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